Chen Q, Elwood M, Campbell I, Cavadino A, Aye P, Tin Tin S
Breast Cancer Res Treat. 2025; .
PMID: 39856462
DOI: 10.1007/s10549-024-07582-6.
Roozitalab M, Prekete N, Allen M, Grose R, Jones J
Adv Exp Med Biol. 2025; 1464():211-235.
PMID: 39821028
DOI: 10.1007/978-3-031-70875-6_12.
Hulahan T, Spruill L, Wallace E, Park Y, West R, Marks J
Int J Mol Sci. 2024; 25(12).
PMID: 38928454
PMC: 11203487.
DOI: 10.3390/ijms25126748.
Skjerven H, Danielsen A, Schlichting E, Sahlberg K, Hofvind S
Breast Care (Basel). 2023; 17(5):486-494.
PMID: 36684407
PMC: 9851073.
DOI: 10.1159/000524564.
Mathelin C, Lodi M, AlGhamdi K, Arboleda-Osorio B, Avisar E, Anyanwu S
Eur J Breast Health. 2022; 18(3):205-221.
PMID: 35855198
PMC: 9255660.
DOI: 10.4274/ejbh.galenos.2022.2022-4-3.
Molecular signatures of in situ to invasive progression for basal-like breast cancers: An integrated mouse model and human DCIS study.
Thennavan A, Garcia-Recio S, Liu S, He X, Perou C
NPJ Breast Cancer. 2022; 8(1):83.
PMID: 35851387
PMC: 9293914.
DOI: 10.1038/s41523-022-00450-w.
Cardiovascular events and mortality in a population-based cohort initially diagnosed with ductal carcinoma in situ.
Yoo T, Park S, Han K, Chae B
BMC Cancer. 2021; 21(1):735.
PMID: 34174850
PMC: 8236151.
DOI: 10.1186/s12885-021-08494-0.
Prediction of Sentinel Lymph Node Metastasis in Breast Ductal Carcinoma Diagnosed by Preoperative Core Needle Biopsy.
Zhang K, Qian L, Zhu Q, Chang C
Front Oncol. 2020; 10:590686.
PMID: 33304849
PMC: 7693536.
DOI: 10.3389/fonc.2020.590686.
Mixed-Methods Study to Predict Upstaging of DCIS to Invasive Disease on Mammography.
Grimm L, Neely B, Hou R, Selvakumaran V, Baker J, Yoon S
AJR Am J Roentgenol. 2020; 216(4):903-911.
PMID: 32783550
PMC: 10729920.
DOI: 10.2214/AJR.20.23679.
Recommendations to improve patient-centred care for ductal carcinoma in situ: Qualitative focus groups with women.
Nyhof B, Wright F, Look Hong N, Groot G, Helyer L, Meiers P
Health Expect. 2019; 23(1):106-114.
PMID: 31532871
PMC: 6978860.
DOI: 10.1111/hex.12973.
Increasing trends in in situ breast cancer incidence in a region with no population-based mammographic screening program: results from Zurich, Switzerland 2003-2014.
Karavasiloglou N, Matthes K, Berlin C, Limam M, Wanner M, Korol D
J Cancer Res Clin Oncol. 2018; 145(3):653-660.
PMID: 30547321
DOI: 10.1007/s00432-018-2822-2.
Mortality of women with ductal carcinoma in situ of the breast: a population-based study from the Girona province, Spain (1994-2013).
Roca-Barcelo A, Vinas G, Pla H, Carbo A, Comas R, Izquierdo A
Clin Transl Oncol. 2018; 21(7):891-899.
PMID: 30536209
DOI: 10.1007/s12094-018-1994-1.
Surgical Upstaging Rates for Vacuum Assisted Biopsy Proven DCIS: Implications for Active Surveillance Trials.
Grimm L, Ryser M, Partridge A, Thompson A, Thomas J, Wesseling J
Ann Surg Oncol. 2017; 24(12):3534-3540.
PMID: 28795370
PMC: 6414216.
DOI: 10.1245/s10434-017-6018-9.
Subsequent risk of ipsilateral and contralateral invasive breast cancer after treatment for ductal carcinoma in situ: incidence and the effect of radiotherapy in a population-based cohort of 10,090 women.
Elshof L, Schaapveld M, Schmidt M, Rutgers E, van Leeuwen F, Wesseling J
Breast Cancer Res Treat. 2016; 159(3):553-63.
PMID: 27624164
PMC: 5021731.
DOI: 10.1007/s10549-016-3973-y.
The distribution of ductal carcinoma in situ (DCIS) grade in 4232 women and its impact on overdiagnosis in breast cancer screening.
van Luijt P, Heijnsdijk E, Fracheboud J, Overbeek L, Broeders M, Wesseling J
Breast Cancer Res. 2016; 18(1):47.
PMID: 27160733
PMC: 4862233.
DOI: 10.1186/s13058-016-0705-5.
Effect of organised mammography screening on stage-specific incidence in Norway: population study.
Lousdal M, Kristiansen I, Moller B, Stovring H
Br J Cancer. 2016; 114(5):590-6.
PMID: 26835975
PMC: 4782212.
DOI: 10.1038/bjc.2016.8.
Cardiovascular morbidity and mortality after treatment for ductal carcinoma in situ of the breast.
Boekel N, Schaapveld M, Gietema J, Rutgers E, Versteegh M, Visser O
J Natl Cancer Inst. 2014; 106(8).
PMID: 25128694
PMC: 4151854.
DOI: 10.1093/jnci/dju156.
Modern mammography screening and breast cancer mortality: population study.
Weedon-Fekjaer H, Romundstad P, Vatten L
BMJ. 2014; 348:g3701.
PMID: 24951459
PMC: 4061379.
DOI: 10.1136/bmj.g3701.
Mammographic performance in a population-based screening program: before, during, and after the transition from screen-film to full-field digital mammography.
Hofvind S, Skaane P, Elmore J, Sebuodegard S, Roth Hoff S, Lee C
Radiology. 2014; 272(1):52-62.
PMID: 24689858
PMC: 4263632.
DOI: 10.1148/radiol.14131502.
Trends in detection of invasive cancer and ductal carcinoma in situ at biennial screening mammography in Spain: a retrospective cohort study.
Roman M, Rue M, Sala M, Ascunce N, Bare M, Baroja A
PLoS One. 2013; 8(12):e83121.
PMID: 24376649
PMC: 3871523.
DOI: 10.1371/journal.pone.0083121.